News

Swiss Deep Tech News & Analysis

Stay informed on the Swiss technology landscape. This is your central resource for Deep Tech News, combining key developments from across the ecosystem with original, data-driven analysis from the Deep Tech Nation Foundation. We track and report on significant technological milestones, funding rounds, and research to provide a comprehensive overview for international investors, partners, and researchers.

Curated Newsfeed

DTN Highlights

  • GlycoEra AG raises $130 Million to advance therapies for autoimmune diseases

    GlycoEra AG, a biotechnology company pioneering best-in-class extracellular protein degraders for the treatment of autoimmune diseases, closed an oversubscribed $130 million Series B financing. The…

    startupticker.ch

    • GlycoEra raised $130M Series B led by Novo Holdings to advance its IgG4 protein degrader into clinical trials this year.
    • GlycoEra's lead program GE8820 selectively degrades pathogenic IgG4 autoantibodies in pemphigus, myasthenia gravis, and other autoimmune diseases.
    startupticker.ch: GlycoEra AG raises $130 Million to advance therapies for autoimmune diseases
  • Hedera Dx raises €15M to bring modern cancer care to patients worldwide

    Hedera Dx, the European techbio company headquartered in Switzerland, just announced the closing of a €15 million Series A financing round to drive advanced cancer…

    startupticker.ch

    • Hedera Dx raised €15M Series A to expand blood-based cancer testing across European hospital labs outside U.S.
    • The company's liquid biopsy platform enables cost-efficient, in-house cancer diagnostics across 11 European countries.
    • Hedera Dx combines molecular profiling with AI analytics to support precision oncology and drug development decisions.
    startupticker.ch: Hedera Dx raises €15M to bring modern cancer care to patients worldwide
  • Promising Swiss innovations unveiled at VivaTech 2025

    The 9th edition of Viva Technology, Europe’s largest startup conference, takes place on June 11-14, 2025, with a strong Swiss delegation comprising 31 technology startups…

    startupticker.ch

    • VivaTech 2025 in Paris hosts 31 Swiss startups at the Swiss Pavilion, with two selected for the Top 100 most promising European startups.
    • Swiss startups at VivaTech span healthtech, AI, renewable energy, and autonomous vehicles, including organ-on-chip and Level 4 delivery tech.
    • The Swiss Pavilion is organized by Presence Switzerland, Switzerland's Embassy in France, and supported by Switzerland Global Enterprise.
    startupticker.ch: Promising Swiss innovations unveiled at VivaTech 2025
  • Gates Foundation awards $5 million grant to Axmed

    As part of the global health movement to expand affordable access to high-quality medicines, the Gates Foundation has awarded a $5 million grant to Axmed,…

    startupticker.ch

    • Gates Foundation awarded Axmed $5M matching funds to boost government procurement of maternal, newborn, and child health commodities in Sub-Saharan Africa.
    • Axmed's platform achieved 20-30% average medicine savings, with some MNCH products reducing costs by up to 80% through aggregated demand.
    • The grant unlocks $10M in MNCH procurement while addressing 287,000 maternal deaths and 2.3M preventable newborn deaths annually.
    startupticker.ch: Gates Foundation awards $5 million grant to Axmed
  • Etops acquires Finanzportal24

    Finanzportal24, a leading provider of financial planning software in Germany, becomes part of Zug-based Etops. With the acquisition, Etops strengthens its position in the market…

    startupticker.ch

    • Etops acquires Finanzportal24, a German financial planning software with 4,500+ users, to expand its WealthTech platform in Europe.
    • Finanzportal24 operates independently while accessing Etops's market reach, infrastructure, and network for growth.
    • The acquisition advances Etops's buy-and-build strategy to build a leading European WealthTech platform for banks, advisors, and insurers.
    startupticker.ch: Etops acquires Finanzportal24
  • Timeline secures USD 250k at XPRIZE Healthspan competition

    Swiss longevity start-up Timeline has been named a Milestone 1 Award Winner in the prestigious XPRIZE Healthspan competition. Selected from hundreds of international teams, Timeline…

    startupticker.ch

    • The $101M XPRIZE competition awards $81M to the grand prize winner in 2030, with clinical trials from 2026-2029 testing therapies on adults aged 50-80.
    startupticker.ch: Timeline secures USD 250k at XPRIZE Healthspan competition
  • CSEM spins out foundry manufacturing photonic integrated circuits

    CCRAFT is a production-ready pure-play foundry offering chips based on Thin-Film Lithium Niobate technology, one of the fastest growing platforms in photonics. Incorporated in April…

    startupticker.ch

    • CCRAFT is the first production-ready foundry for Thin-Film Lithium Niobate photonic chips, offering 8x faster speed and 10x lower energy use.
    • The company plans to expand Neuchâtel production to deliver 12 million chips annually by 2030, targeting 30% global photonic chip market share.
    • TFLN technology enables quantum technologies, advanced sensing, lidar, and space systems with low optical losses and wide transparency ranges.
    startupticker.ch: CSEM spins out foundry manufacturing photonic integrated circuits
  • CHF 6 million to bring pre-IPO investment opportunities to blockchain

    Geneva-based Colb Asset SA, focussed on real-world asset tokenization, has closed an oversubscribed CHF 6 million seed extension round. The investment comes from a private…

    startupticker.ch

    • Colb Asset SA raised CHF 6 million in an oversubscribed seed extension from a major $20+ billion asset manager.
    • Funding accelerates blockchain tokenization of pre-IPO equity, wealth strategies, and investment funds for global access.
    • Colb tokenizes energy, infrastructure, utilities, and agribusiness assets to democratize institutional-grade investments worldwide.
    startupticker.ch: CHF 6 million to bring pre-IPO investment opportunities to blockchain
  • Multi-year deals for four cleantech startups

    Companies that collaborate with startups and implement their solutions play a vital role in helping these young businesses scale and reach broader markets. Recent multi-year…

    startupticker.ch

    • Terralayr's virtual battery deal with Vattenfall lets smaller decentralized systems access large-scale agreements, expanding storage financing in Germany.
    • Voltiris and AIKO Energy deploy spectral-filtering solar in Chinese greenhouses for simultaneous crop and clean energy production.
    • Climeworks signed its first Japanese carbon removal contract with NYK shipping, providing CO₂ removal solutions through 2028.
    startupticker.ch: Multi-year deals for four cleantech startups
  • HAYA Therapeutics banks $65 million Series A funding

    Led by Sofinnova Partners and Earlybird Venture Capital, Haya Therapeutics’ Series A funding round also involved a syndicate of investors, including Eli Lilly and Company.…

    startupticker.ch

    • HAYA Therapeutics raised $65M Series A funding led by Sofinnova and Earlybird for HTX-001, an lncRNA therapy targeting heart failure.
    • HAYA's platform targets the regulatory genome to reprogram disease-driving cell states rather than just manage symptoms.
    • HAYA plans to expand into pulmonary fibrosis, obesity, and age-related diseases using its proprietary genome-mapping technology.
    startupticker.ch: HAYA Therapeutics banks $65 million Series A funding
  • Digital exchange SDX attracts Citi as partner

    Expected to be live by the third quarter of 2025, leading global bank Citi and SDX, part of SIX Group, are developing a scalable solution…

    startupticker.ch

    • Citi and SDX launch tokenized platform for pre-IPO shares in Q3 2025, improving institutional investor access to private companies.
    • SDX's regulated blockchain Central Securities Depository simplifies liquidity management and cap table control for high-growth private firms.
    • Sygnum and SBI Digital Markets will distribute pre-IPO equities to clients across Europe and Asia.
    startupticker.ch: Digital exchange SDX attracts Citi as partner
  • Private biotech companies set new records

    The 2025 edition of the Swiss Biotech Report, launched today by the Swiss Biotech Association together with EY and eight other partner organizations at the…

    startupticker.ch

    • Swiss biotech revenues hit CHF 7.2 billion in 2024, with private companies surpassing CHF 2 billion for the first time.
    • No Swiss biotech companies went public in 2024 due to constrained capital markets, with no IPO wave expected in 2025.
    • Investment favors experienced serial entrepreneurs, creating a divide between well-funded and under-capitalized start-ups.
    startupticker.ch: Private biotech companies set new records